Stock MDB MEDICOFARMA BIOTECH SA
Add to a list
To use this feature you must be a member
Log inSign up

Financials Medicofarma Biotech SA

Equities

MDB

PLINBOK00010

Biotechnology & Medical Research

End-of-day quote Warsaw S.E.
Other stock markets
 03:30:00 07/06/2024 am IST 		5-day change 1st Jan Change
0.784 PLN -2.24% Intraday chart for Medicofarma Biotech SA -5.77% -27.74%
13/05 Medicofarma Biotech SA Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
06/02 Medicofarma Biotech SA Reports Earnings Results for the Full Year Ended December 31, 2023 CI

Valuation

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Capitalization 1 1.357 2.09 19.81 115.5 78.51 73.76
Enterprise Value (EV) 1 1.003 2.093 20.13 115.5 78.01 75.14
P/E ratio 27.6 x -6.06 x -21.6 x -537 x -49.4 x -21.4 x
Yield - - - - - -
Capitalization / Revenue 0.27 x 0.66 x 5.43 x 34.6 x 18.5 x 98.2 x
EV / Revenue 0.2 x 0.66 x 5.52 x 34.6 x 18.3 x 100 x
EV / EBITDA 9.58 x -6.18 x -59.1 x 173 x 454 x -137 x
EV / FCF -2.74 x -8.52 x 101 x -45.5 x 78.6 x -94.9 x
FCF Yield -36.5% -11.7% 0.99% -2.2% 1.27% -1.05%
Price to Book 1.31 x 3.04 x -86.6 x 8.14 x 6.22 x 8.04 x
Nbr of stocks (in thousands) 6,784 6,784 6,784 67,965 67,978 67,978
Reference price 2 0.2000 0.3080 2.920 1.700 1.155 1.085
Announcement Date 10/05/19 01/06/20 22/03/21 30/05/22 30/05/23 31/05/24
1PLN in Million2PLN
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net sales 1 4.969 3.185 3.65 3.337 4.252 0.7508
EBITDA 1 0.1047 -0.3384 -0.3407 0.6665 0.1719 -0.5475
EBIT 1 0.0752 -0.369 -0.3636 -0.2846 -1.577 -2.632
Operating Margin 1.51% -11.59% -9.96% -8.53% -37.07% -350.58%
Earnings before Tax (EBT) 1 0.0365 -0.3449 -0.8954 -0.2152 -1.589 -3.652
Net income 1 0.0491 -0.3449 -0.9159 -0.2152 -1.589 -3.439
Net margin 0.99% -10.83% -25.09% -6.45% -37.38% -458.07%
EPS 2 0.007239 -0.0508 -0.1350 -0.003166 -0.0234 -0.0506
Free Cash Flow 1 -0.3666 -0.2458 0.1993 -2.536 0.9918 -0.7918
FCF margin -7.38% -7.72% 5.46% -75.99% 23.32% -105.47%
FCF Conversion (EBITDA) - - - - 577.09% -
FCF Conversion (Net income) - - - - - -
Dividend per Share - - - - - -
Announcement Date 10/05/19 01/06/20 22/03/21 30/05/22 30/05/23 31/05/24
1PLN in Million2PLN
Estimates

Balance Sheet Analysis

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net Debt 1 - 0 0.32 - - 1.39
Net Cash position 1 0.35 - - 0.08 0.51 -
Leverage (Debt/EBITDA) - -0.009458 x -0.9463 x - - -2.535 x
Free Cash Flow 1 -0.37 -0.25 0.2 -2.54 0.99 -0.79
ROE (net income / shareholders' equity) 4.87% -40.1% -399% -3.08% -11.9% -31.6%
ROA (Net income/ Total Assets) 2.76% -15.2% -25.5% -2.07% -5.95% -10.5%
Assets 1 1.778 2.263 3.595 10.38 26.73 32.76
Book Value Per Share 2 0.1500 0.1000 -0.0300 0.2100 0.1900 0.1300
Cash Flow per Share 2 0.0500 0.0100 0 0 0.0100 0
Capex - - - 2.3 1.21 1.11
Capex / Sales - - - 68.9% 28.41% 147.35%
Announcement Date 10/05/19 01/06/20 22/03/21 30/05/22 30/05/23 31/05/24
1PLN in Million2PLN
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sector Other Biotechnology & Medical Research

1st Jan change Capi.
MEDICOFARMA BIOTECH SA Stock Medicofarma Biotech SA
-27.74% 1.34Cr
MODERNA, INC. Stock Moderna, Inc.
+51.85% 5.79TCr
LONZA GROUP AG Stock Lonza Group AG
+41.42% 4.03TCr
IQVIA HOLDINGS INC. Stock Iqvia Holdings Inc.
-5.25% 3.99TCr
CELLTRION, INC. Stock Celltrion, Inc.
-5.16% 2.85TCr
ICON PUBLIC LIMITED COMPANY Stock ICON Public Limited Company
+12.79% 2.64TCr
ALNYLAM PHARMACEUTICALS, INC. Stock Alnylam Pharmaceuticals, Inc.
-20.18% 1.93TCr
MEDPACE HOLDINGS, INC. Stock Medpace Holdings, Inc.
+30.88% 1.24TCr
BIO-TECHNE CORPORATION Stock Bio-Techne Corporation
+0.61% 1.22TCr
UNITED THERAPEUTICS CORPORATION Stock United Therapeutics Corporation
+25.06% 1.22TCr
Other Biotechnology & Medical Research
  1. Stock Market
  2. Equities
  3. MDB Stock
  4. Financials Medicofarma Biotech SA